Janssen Pharmaceutical K.k.

This study is testing whether a drug called apalutamide, when given with a hormone-blocking injection, can shrink tumors in people with advanced salivary gland cancer. It is for patients whose cancer has spread or returned and whose tumors test positive for a specific protein cal…

This study is testing an immunotherapy drug called teclistamab in Japanese patients whose multiple myeloma has returned or stopped responding to standard treatments. The first part checks the drug's safety, and the second part measures how well it works to shrink the cancer. Abou…

This study is testing an experimental medication called JNJ-77242113 for people with two severe forms of psoriasis: generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). The main goal is to see how well the drug improves skin symptoms and overall condition over 1…

This is an early safety study for a new device called TAR-210, which is placed in the bladder to slowly release a cancer drug. It is being tested in 5 Japanese patients with a specific type of recurring bladder cancer that has certain genetic changes. The main goal is to see how …